首页|期刊导航|中国病理生理杂志|Aurora激酶A通过磷酸化SREBP2调控胆固醇合成代谢促进食管鳞状细胞癌恶性进展

Aurora激酶A通过磷酸化SREBP2调控胆固醇合成代谢促进食管鳞状细胞癌恶性进展OA

Aurora kinase A regulates cholesterol synthesis metabolism via SREBP2 phosphorylation to promote malignant progression in esophageal squa-mous cell carcinoma

中文摘要英文摘要

目的:探讨Aurora激酶A(Aurora kinase A,AURKA)对食管鳞状细胞癌(esophageal squamous cell carcinoma,ESCC)细胞胆固醇合成代谢的调控作用及分子机制.方法:在人ESCC细胞系KYSE-150中,分别构建AURKA过表达、敲减及激酶失活突变体(D256A)细胞株,并设置空载/阴性对照;通过敲减固醇调节元件结合蛋白2(sterol regulatory element-binding protein 2,SREBP2)进行挽救(rescue)实验.采用油红O染色观察脂滴积累;比色法检测细胞内总胆固醇与游离胆固醇水平;菲律宾菌素III(filipin III)染色分析膜胆固醇分布;Western blot检测胆固醇合成通路关键分子SREBP2及其下游分子3-羟基-3-甲基戊二酰辅酶A还原酶(3-hydroxy-3-methylglutaryl-coen-zyme A reductase,HMGCR)的表达.体内实验使用雌性BALB/c裸鼠建立皮下移植瘤模型,随机分为3组(n=5),分别接种对照、过表达野生型AURKA及D256A突变型AURKA的细胞,观察肿瘤生长并检测瘤内胆固醇代谢相关分子表达.结果:在KYSE-150细胞中,过表达AURKA能显著增加脂滴积累,提升总胆固醇和游离胆固醇水平,影响膜胆固醇分布(P<0.05),而敲减AURKA则产生相反效应.AURKA过表达可显著上调SREBP2及其下游分子HMGCR的蛋白表达水平(P<0.05).敲减SREBP2可部分逆转由AURKA过表达所引发的胆固醇合成的增强及细胞增殖和迁移能力的提升(P<0.05).激酶失活突变体D256A则抑制了SREBP2的磷酸化及其下游脂代谢通路的激活(P<0.05).体内实验证实,与过表达野生型AURKA相比,接种D256A突变体细胞的裸鼠,其肿瘤生长受到显著抑制,瘤内胆固醇含量显著降低,且SREBP2和HMGCR的表达水平亦显著下调(P<0.05).结论:在ESCC细胞中,AURKA通过其激酶活性磷酸化并激活SREBP2,驱动胆固醇合成代谢重编程,进而促进细胞增殖和迁移.

AIM:To investigate the regulatory role and molecular mechanism of Aurora kinase A(AURKA)on cholesterol metabolism in esophageal squamous cell carcinoma(ESCC)cells.METHODS:Cells with AURKA overex-pression,knockdown,and kinase-inactive mutant(D256A)were constructed in the human ESCC KYSE-150 cell line,along with empty vector/negative controls.Rescue experiments were performed by knocking down sterol regulatory element-binding protein 2(SREBP2).Oil Red O staining was used to evaluate lipid droplet accumulation,and colorimetric assays were performed to detect total cholesterol and free cholesterol levels.Filipin III staining was used to analyze membrane cholesterol distribution,and Western blots were conducted to examine the expression and phosphorylation of key mole-cules in the cholesterol synthesis pathway,SREBP2 and its downstream molecule 3-hydroxy-3-methylglutaryl-coenzyme A reductase(HMGCR).A subcutaneous in vivo xenograft tumor model was established in female BALB/c nude mice.The mice were randomly assigned to three groups(n=5)and inoculated with control cells,cells overexpressing wild-type AUR-KA,or cells expressing the D256A mutant.Tumor growth was monitored,and the expression of cholesterol metabolism-re-lated molecules in the tumors was analyzed.RESULTS:In KYSE-150 cells,overexpression of AURKA significantly in-creased lipid droplet accumulation,elevated total and free cholesterol levels,and affected membrane cholesterol distribu-tion(P<0.05),while the knockdown of AURKA produced the opposite effects.AURKA overexpression significantly upreg-ulated SREBP2 protein expression levels and its downstream molecule HMGCR(P<0.05).Knockdown of SREBP2 par-tially ameliorated the enhanced cholesterol synthesis,cell proliferation,and migration induced by AURKA overexpression(P<0.05).The kinase-inactive mutant D256A inhibited SREBP2 phosphorylation and the activation of its downstream lip-id metabolism pathway(P<0.05).In vivo experiments confirmed that tumor growth in nude mice inoculated with D256A mutant cells was significantly inhibited,intratumoral cholesterol content was significantly reduced,and the expression lev-els of SREBP2 and HMGCR were also significantly downregulated compared with the inoculation of cells overexpressing wild-type AURKA(P<0.05).CONCLUSION:In ESCC cells,AURKA phosphorylated and activated SREBP2 in a ki-nase activity-dependent manner,driving cholesterol synthesis metabolic reprogramming and thereby promoting cell prolif-eration and migration.

石科;李文清;李悦淇;王君;杨亮;赵亚军

河南医学高等专科学校检验学院生物化学与医学遗传学教研室,河南 郑州 451191河南医学高等专科学校检验学院生物化学与医学遗传学教研室,河南 郑州 451191郑州大学第一附属医院眼科,河南 郑州 450008河南医学高等专科学校检验学院生物化学与医学遗传学教研室,河南 郑州 451191河南医学高等专科学校检验学院微生物与免疫学教研室,河南 郑州 451191郑州市第二人民医院检验科,河南 郑州 450006

医药卫生

Aurora激酶A食管鳞状细胞癌胆固醇合成代谢固醇调节元件结合蛋白23-羟基-3-甲基戊二酰辅酶A还原酶

Aurora kinase Aesophageal squamous cell carcinomacholesterol synthesis metabolismsterol regulatory element-binding protein 23-hydroxy-3-methylglutaryl-coenzyme A reductase

《中国病理生理杂志》 2026 (8)

1550-1558,9

河南省科技攻关项目(No.232102310220)河南省高等学校重点科研项目计划(No.23A320068)河南省医学科技攻关联合共建项目(No.LHGJ20220707)郑州市医疗卫生领域科技创新指导计划项目(No.2024YLZDJH219)

10.3969/j.issn.1000-4718.2026.08.008

评论